Not A Member?       Forget Password?
          Click HERE                   Click HERE
   and Register FREE
Fibrocell Science, Inc.
( :FCSC ) / David Pernock
diaDexus, Inc.
( OTCBB:DDXS ) / Dr. Brian Ward
NovaBay Pharmaceuticals, Inc.
( NYSE:NBY ) / Ron Najafi, Ph.D. Thomas Paulson, M.B.A.
EnerJex Resources, Inc.
( OTCBB:ENRJ ) / Robert Watson, Jr. Atticus Lowe
League Now Holdings Corporation (Infiniti Systems Group, Inc.)
( OTCBB:LNWZ ) / Mr. John L. Bianco Mr. D. Bruce Veness
Sunshine Biopharma, inc.
( OTCBB:SBFM ) / Steve N. Slilaty Camille Sebaaly
TheraBiogen, Inc.
( OTCBB:TRAB ) / Kelly Hickel
Trimedyne, Inc.
( OTCBB:TMED ) / Marvin P. Loeb
XsunX Inc.
( OTCBB:XSNX ) / Mr. Tom M. Djokovich
July 25, 2015 CEOcast Weekly Newsletter
Companies featured in this edition of the newsletter: None This week the stock market flirted with its first weekly decline in 4 weeks, but managed to secure another round of weekly gains. This pa... Click here for more...

Enzo Biochem, Inc.
Enzo Biochem, Inc. is engaged in the research, development and manufacture of innovative health care products based on molecular biology and genetic engineering techniques. Enzo is a growth-oriented integrated life sciences and biotechnology company focused on harnessing biological processes to develop research tools, diagnostics and therapeutics and serves as a provider of test services, including esoteric tests, to the medical community.
Spotlight Innovation, Inc.
Spotlight Innovation Inc. identifies and acquires rights to innovative and proprietary platform technology candidates with a focus on cancer drugs and related treatment therapies, solutions for infectious disease, and other specialty and unique opportunities. It provides solutions for healthcare-focused companies commercializing healthcare intellectual property.
Opsens Inc.
Opsens Inc. engages in the development, manufacture, sale, and installation of fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. It operates through Opsens and Opsens Solutions segments. The company primarily focuses on measuring FFR in interventional cardiology

Copyright © 2001-2016. All Rights Reserved. Disclaimer | Privacy Policy